IBDEI0C9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5820,0)
 ;;=214.9^^41^490^39
 ;;^UTILITY(U,$J,358.3,5820,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5820,1,4,0)
 ;;=4^214.9
 ;;^UTILITY(U,$J,358.3,5820,1,5,0)
 ;;=5^Lipoma NOS
 ;;^UTILITY(U,$J,358.3,5820,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,5821,0)
 ;;=703.0^^41^490^40
 ;;^UTILITY(U,$J,358.3,5821,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5821,1,4,0)
 ;;=4^703.0
 ;;^UTILITY(U,$J,358.3,5821,1,5,0)
 ;;=5^Onychocryptosis
 ;;^UTILITY(U,$J,358.3,5821,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,5822,0)
 ;;=528.2^^41^490^43
 ;;^UTILITY(U,$J,358.3,5822,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5822,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,5822,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,5822,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,5823,0)
 ;;=692.72^^41^490^44
 ;;^UTILITY(U,$J,358.3,5823,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5823,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,5823,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,5823,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,5824,0)
 ;;=692.6^^41^490^46
 ;;^UTILITY(U,$J,358.3,5824,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5824,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,5824,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,5824,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,5825,0)
 ;;=698.0^^41^490^62
 ;;^UTILITY(U,$J,358.3,5825,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5825,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,5825,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,5825,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,5826,0)
 ;;=698.9^^41^490^61
 ;;^UTILITY(U,$J,358.3,5826,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5826,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,5826,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,5826,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,5827,0)
 ;;=696.1^^41^490^63
 ;;^UTILITY(U,$J,358.3,5827,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5827,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,5827,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,5827,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,5828,0)
 ;;=287.0^^41^490^64
 ;;^UTILITY(U,$J,358.3,5828,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5828,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,5828,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,5828,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,5829,0)
 ;;=782.1^^41^490^65
 ;;^UTILITY(U,$J,358.3,5829,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5829,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,5829,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,5829,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,5830,0)
 ;;=706.2^^41^490^69
 ;;^UTILITY(U,$J,358.3,5830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5830,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,5830,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,5830,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,5831,0)
 ;;=690.10^^41^490^72
 ;;^UTILITY(U,$J,358.3,5831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5831,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,5831,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,5831,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,5832,0)
 ;;=702.11^^41^490^70
 ;;^UTILITY(U,$J,358.3,5832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5832,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,5832,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,5832,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,5833,0)
 ;;=702.19^^41^490^71
 ;;^UTILITY(U,$J,358.3,5833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5833,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,5833,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,5833,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,5834,0)
 ;;=686.9^^41^490^73
 ;;^UTILITY(U,$J,358.3,5834,1,0)
 ;;=^358.31IA^5^2
